Patent US4885276A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4885276A Expired / Lapsed US ⏱️ 0.0 years remaining

Cyclosporin analogs with modified "C-9 amino acids"

Assignee: Merck and Co Inc
•
Filing: 1988-10-24
•
Granted: 1989-12-05
•
Expires: 2008-10-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New cyclosporin analogs with modified "C-9 amino acids" have been made and are found to be effective immunosuppressive agents.

Inventors

  • 👤 Bruce E. Witzel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 16:18
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/64; C07K7/645; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 263 words
A compound of formula ##STR18## wherein R 1 is MeBMT; R 2 is ##STR19## where X, R, R a and R e are as defined below; R is (1) hydrogen; (2) loweralkyl; (3) loweralkenyl; (4) haloloweralkyl; (5) aryl; (6) oxyloweralkyl comprising lower alkyl and hydroxy lower alkyl; (7) thioloweralkyl comprising alkyl thio lower alkyl and mercapto lower alkyl; (8) heteroaryl; the aryl or heteroaryl group above can be substituted with one or more functional groups selected from a group consisting of (a) C 1-6 alkyl, (b) C 1-6 alkanoyl; (c) C 1-6 haloalkyl; (d) halo; (e) cyano; (f) hydroxy C 1-3 alkyl; (g) C 1-6 alkoxy; (h) ##STR20## where n is 0, 1 or 2; (i) --NR b COR c wherein R b and R c independently are H or C 1-6 alkyl; (j) --NO 2 ; (k) --NR b R c ; (l) --OR b ; (m) --CONR b R c (n) --COR b ; (o) --NR b CONR b R c ; (p) --NR b COR c ; (q) --OCOR b ; (r) --SCOR b ; or (s) --OCH 2 O--; and X is S, SO, SO 2 , O, or NR b R a is loweralkyl; R e is loweralkyl; loweralkylphenyl; or aryl; R 3 is sarcosyl; α-(methylmercapto)-sarcosyl; N-methyl-D-alanyl; N-methyl-L-alanyl; or D-prolyl; R 4 is N-methyl-L-leucyl; R 5 is L-valyl; or norvalyl; R 6 is N-methyl-L-leucyl; R 7 is L-ananyl; L-2-aminobutyryl; or L-phenylalanyl;; R 8 is D-alanyl or L-alanyl; R 9 is N-methyl-L-leucyl; or N-methyl-L-valyl; R 10 is N-methyl-L-leucyl; or L-leucyl; and R 11 is N-methyl-L-valyl; L-valyl; N-methylleucyl; or L-2-aminobutyryl.
Claim 2
Dependent Claim 263 words
A compound of formula ##STR18## wherein R 1 is MeBMT; R 2 is ##STR19## where X, R, R a and R e are as defined below; R is (1) hydrogen; (2) loweralkyl; (3) loweralkenyl; (4) haloloweralkyl; (5) aryl; (6) oxyloweralkyl comprising lower alkyl and hydroxy lower alkyl; (7) thioloweralkyl comprising alkyl thio lower alkyl and mercapto lower alkyl; (8) heteroaryl; the aryl or heteroaryl group above can be substituted with one or more functional groups selected from a group consisting of (a) C 1-6 alkyl, (b) C 1-6 alkanoyl; (c) C 1-6 haloalkyl; (d) halo; (e) cyano; (f) hydroxy C 1-3 alkyl; (g) C 1-6 alkoxy; (h) ##STR20## where n is 0, 1 or 2; (i) --NR b COR c wherein R b and R c independently are H or C 1-6 alkyl; (j) --NO 2 ; (k) --NR b R c ; (l) --OR b ; (m) --CONR b R c (n) --COR b ; (o) --NR b CONR b R c ; (p) --NR b COR c ; (q) --OCOR b ; (r) --SCOR b ; or (s) --OCH 2 O--; and X is S, SO, SO 2 , O, or NR b R a is loweralkyl; R e is loweralkyl; loweralkylphenyl; or aryl; R 3 is sarcosyl; α-(methylmercapto)-sarcosyl; N-methyl-D-alanyl; N-methyl-L-alanyl; or D-prolyl; R 4 is N-methyl-L-leucyl; R 5 is L-valyl; or norvalyl; R 6 is N-methyl-L-leucyl; R 7 is L-ananyl; L-2-aminobutyryl; or L-phenylalanyl;; R 8 is D-alanyl or L-alanyl; R 9 is N-methyl-L-leucyl; or N-methyl-L-valyl; R 10 is N-methyl-L-leucyl; or L-leucyl; and R 11 is N-methyl-L-valyl; L-valyl; N-methylleucyl; or L-2-aminobutyryl.
Claim 3
Dependent Claim 38 words
The compound of claim 1 wherein R is (1) hydrogen; (2) C 1-6 alkyl; (3) --CF 3 ; (4) phenyl; R a is C 1-6 alkyl; X is S or O; and R e is C 1-6 alkyl.
Claim 4
Dependent Claim 25 words
The compound of claim 2 wherein R is C 1-6 alkyl or phenyl; R a is methyl; X is S; and R e is methyl.
Claim 5
Dependent Claim 115 words
A compound according to claim 1, selected from the group consisting of compounds of the formula (I) wherein: R 7 is Ala, R 8 is D-Ala, R 9 is MeLeu, R 10 is MeLeu, R 11 is MeVal, and (1) R 1 is MeBMT, R 2 is MMT, R 3 is Sar, R 4 is MeLeu, R 5 is Val, R 6 is MeLeu; (2) R 1 is MeBMT, R 2 is 2S,3R,4S)-N,4-dimethyl 4-(isopropyl-thiomethyl)-threonyl, R 3 is Sar, R 4 is MeLeu, R 5 is Val, R 6 is MeLeu; or (3) R 1 is MeBMT, R 2 N-methyl-D-alanine, R 3 is Sar, R 4 is MeLeu, R 5 is Val, R 6 is MeLeu.
Claim 6
Dependent Claim 29 words
A pharmaceutical composition for the prevention of immunoregulatory disorders or diseases comprising a pharmaceutical carrier and a therapeutically effective amount of compound of formula (I), according to claim 1.
Claim 7
Dependent Claim 29 words
A pharmaceutical composition for the treatment of immunoregulatory disorders or diseases comprising a pharmaceutical carrier and a therapeutically effective amount of compound of formula (I), according to claim 4.
Claim 8
Dependent Claim 35 words
A method for the prevention of immunoregulatory disorders or diseases comprising the administration to a mammalian species in need of such prevention an effective amount of a compound of formula (I) according to claim 1.
Claim 9
Dependent Claim 35 words
A method for the treatment of immunoregulatory disorders or diseases compromising the administration to a mammalian species in need of such treatment an effective amount of a compound of formula (I) according to claim 4.

References Cited (Backward Citations)

US4396542A Cited
US4771122A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-12-04 1993-06-05 1993-12-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-12-04 1997-06-05 1997-12-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-12-04 2001-06-05 2001-12-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag